Abstract -Data are presented concerning the possibility of using the micronuclei (MN) level as a biomarker for cytogenetic effects in exfoliated epithelial cells of cancer patients under therapy. The number of MN in buccal cells of cancer patients under chemotherapy are very contradictory. A significant dose-dependent increment of MN in tumor and normal epithelial cells due to radiotherapy was shown in most investigations. Evaluation of MN induced by radiotherapy in exfoliated tumor cells can potentially identify the radiosensitivity of tumors and the outcome of treatment after the first fractions of irradiation. This technique is almost completely noninvasive and easily done in accessible primary cancers (oral cavity and uterine cervix).
1 It is well established that radio-and chemotherapy widely used for treatment of cancer patients induce chromosomal aberrations and micronuclei (MN) both in tumor [1] [2] [3] [4] and normal (healthy) cells [5, 6] . Because of some technical difficulties (invasive procedure to obtain tumor cells during and after treatment), cytogenetic disturbances are mostly studied in lymphocytes [7, 8] . These cells are the most widely used target for biomonitoring of cytogenetic effects of cancer treatment.
Of course, it would be of interest to monitor cytogenetic alterations not in surrogate tissue (lymphocytes) but in tumor and epithelial cells. It is noteworthy that about 90% of all human tumors are derived from epithelial tissues [9, 10] . An MN assay in exfoliated human epithelial cells is used to study clastogenicaneugenic effects of agents of various origin [11, 12] . It has been shown that exposure of persons to certain environmental and occupational pollutants can lead to an increased level of MN in inepithelial cells. Some lifestyle habits, such as tobacco smoking, and that, areca nut, and betel chewing could also be the causes of MN induction in oral mucosal cells. In some diseases, including precancerous diseases and cancer itself, the increment of MN was also frequently observed [11, 12] .
The aim of this paper is to evaluate the data concerning the MN level in exfoliated epithelial cells of cancer patients as possible biomarkers of the cytogenetic effect of antiblastic chemo-and radiotherapy. In [11] , three articles were cited concerning radiotherapy of oral cancer (eight subjects in total, with an increase in MN not affected by tumor cells in all cases); one con- 1 The text was submitted by the author in English.
cerning treatment of thyroid cancer with 131 I (31 subjects, negative result), and one concerning cancer chemotherapy (seven subjects, positive results in five persons, and correlation of MN data in lymphocytes) [11] . It should be added to the last cited paper [13] , that the increment of MN both in exfoliated epithelial cells and lymphocytes were not observed in two subjects treated only with interferon. Hence, correlation was observed between the correspondence of two types of cells to genotoxic action of chemotherapeutic drugs.
The most important data concerning MN induction in exfoliated epithelial cells by radio-and chemotherapy are presented in Tables 1 and 2 (age and sex of subjects, the type of stain used, and the number of cells studied). As concerns the accuracy of scoring and evaluation of the number of MN in mucosal cells, the most important impact could have only the stain used (DNAspecific or not) and the number of studied cells [14] [15] [16] .
Only three papers were found in Medline on MN induction in exfoliated epithelial cells due to antiblastic chemotherapy. One of them had already been analyzed by Majer et al. [13] . In [17] , four males and five females with lymphogranulomatosis, four males with lung cancer, and seven females with breast cancer were analyzed a week after various schedules of antiblastic chemotherapy. A significantly increased number of MN was observed. In 21 Mexican patients with various localization of tumors treated with isophosphamide+epirubicin, a significantly increased number of MN was recorded (from 1.2‰ before to 2.6‰ after treatment) [18] . In 14 patients (mostly with oral and penile cancer) treated with carboplatin + 5-fluorouracil, and 6 patients (3 with penile, 1 with prostate, and 2 with oral cancer) treated with cisDDP+5-fluorouracil, no such effect was recorded. In this paper, both primary NERSESYAN patients and patients subjected to second and even the third courses of chemotherapy were studied. Based on the data presented by the authors, the number of cells with MN in only primary cancer patients treated with three chemotherapeutic schedules were calculated. In total, 19 were primary, and MN frequencies were 1.6 ± 0.4‰ before and 2.6 ± 0.7‰ after treatment ( p > 0.05, Mann Whitney test). In ten patients treated with carboplatin + 5-fluorouracil MN numbers were 0.95 ± 0.12‰ before and 1.35 ± 0.42‰ after treatment, and in seven patients treated with isophosphamide+epirubi-cin, the frequencies were 2.9 ± 1.0‰ before and 4.9 ± 1.6‰ after treatment ( p > 0.05 in both cases, Mann Whitney U-test). In all cases, no significant increase of MN was observed. Torres-Bugarin et al. [18] mentioned that many patients under chemotherapy had signs of toxicity-the presence of a lot of buccal cell with karyolysis. Hence, two papers reported on a significant increment of MN induced by antiblastic chemotherapy, and one reported the same effect due to only one schedule of therapy. Correlations between MN level induction in somatic epithelial cells and results of treatment are unknown because no data have been published about the outcome of treatment of the patients after chemotherapy.
Although contradictory results were published concerning chemotherapy action on the MN level in buccal mucosa cells, it is noteworthy that in two studies the significantly increased level of MN was observed in buccal cells of nurses handling cytostatic drugs (1.6-2.0-fold) [19] [20] [21] , and in one case an insignificant increase of twofold [22] .
The data concerning the frequencies of MN induced by radiotherapy in normal and tumor epithelial cells are presented in Tables 2 and 3 , respectively. The most important data of four papers in Table 2 are presented on the studied cells with no sign of pathology [23] [24] [25] [26] ; e.g., they were obtained from the opposite site of tumor localization, or from the same site, close to the tumor. In four other papers, the results of studies of tumor cells during and/or after radiotherapy are presented (Table 3 ) [27] [28] [29] [30] . Both in normal and tumor cells, a significant increase of MN was observed due to radiation. It is important that in normal cervical [23] and buccal [25, 26] cells of patients under radiotherapy, the MN level increased linearly until a specific dose (mostly, about 25-35 Gy), and then even decreased after additional doses of radiation. In cervix cells, the frequency of cells with MN was significantly higher after 35 Gy (8‰) than the level after 70 Gy (7.4‰) [23] . In buccal mucosa, 8.8‰ cells with MN were observed after the dose of 48 Gy, and only 7.6‰ after 68 Gy [26] . This phenomenon was observed also in lymphocytes of head-and-neck and cervix cancer patients during radiotherapy where the frequencies of micronuclei increased during the first half of therapy and declined thereafter, reaching, in some patients, values below the pretreatment level [26, 31] . In all mentioned cases no attention was paid to the outcome of the therapy. The oral mucosa cells of cancer patients under radiotherapy were studied along with the cervix cells. Unlike the cervix cells, even after receiving a high local dose of radiation (about 70 Gy), no significant increase was observed in the oral cells [23] . Table 1 -3: ↑ -significant increase; ↔ -no effect; -either increase or decrease, but not significant; pts-patients; f-female, m-male.
↔ ↔
In four papers, the MN level was studied in cervix and oral mucosa tumor cells (Table 3 ) [24, [27] [28] [29] [30] . In some cases, MN frequencies in the tumor cells were higher than in the normal mucosa cells (e.g., 15‰ [27] and 11‰ [28] compared with healthy subjects from India-0.7-4.0‰ [32] ). In two studies, a linear increase in the MN number in cancer cells with the dose of radiation was observed [24, 30] . In the exfoliated oral tumor cells of patients with a good outcome of radiotherapy, the number of cells with MN was significantly higher than in the ones resistant to therapy [28] . In cervix tumor, the MN of cells have good predictive value after one week of therapy-a high number of MN compared to the background level predict good response to radiotherapy [29] . The same results were obtained by the research group of Wiedel-they investigated the tumor cells obtained by biopsy instead of exfoliated tumor cells [3, 4] .
In addition to MN in exfoliated cells, some groups of investigators also studied MN chromosomal aberrations and DNA damage (by means of the comet assay) in lymphocytes [25, 26] . Good correlation was observed with these genotoxicity endpoints, but all of them were more sensitive to radiation than the MN assay in exfoliated cells. Two to three months after the end of radiotherapy, the level of MN in buccal cells, but not in lymphocytes, decreased. The number of cells with MN in buccal mucosa was higher than in the negative control, but not statistically significant [25] . In the same paper, the authors paid attention to the influence of smoking on the MN level induced by radiotherapy and found no effect even in heavy smokers (30 or more cigarettes per day).
It is well known that in lymphocytes of primary cancer patients, independent of stage and localization of the tumor, a significantly increased number of chromosomal aberrations and MN was reported [33] [34] [35] . In the normal buccal cells of Armenian patients with oral cavity cancer [24] and Brazilian patients with head and neck cancer [25] , almost the same frequencies of MN were observed (0.8-0.9‰). This level did not differ significantly from the data obtained on healthy persons of the same ethnicity-the negative control in both papers were 0.7‰ in Armenians and 0.5‰ in Brazilians [17, 25] . In Chinese patients with nasopharyngeal cancer, 2.3‰ cells with MN were observed [26] , which is very close to the data reported on the healthy persons from China [36] . As for Mexican cancer patients, in all three represented groups, the number of cells with MN significantly increased compared with 43 healthy persons from the same study (0.6‰) [18] . However, at the same time, 37 primary cancer patients with various localization of tumors in the same study used as a control did not show any increase compared with healthy [26] subjects (0.8‰). It could be because of the fact that patients previously treated with chemotherapy were included in the mentioned three groups along with primary patients. Anyway, the data concerning the background level of MN in epithelial cells of primary cancer patients are very contradictory. In the head-and-neckcancer patients from Brazil, no difference was observed in MN frequency in the patients and the control subjects, and also between the patients at various stages of tumor [25] . But the results of some investigations witness about significantly increased number of MN in cancer patients. In 12 breast, 10 lung, 16 lymph nodes, and 21 cervix cancer patients from Armenia [37] and 30 oral cancer patients from Brazil [38] , a 2-to 3-fold significant increase compared with the healthy subjects was reported. In the normal cervix cells of the patients with cervix cancer from Armenia, the level of MN is significantly higher (3.9‰) than in healthy females with normal menstrual function, and also in pre-and postmenopausal ones [39, 40] . The background level of MN in epithelial cells of cancer patients and even in healthy persons also warrants further investigations [41] .
Hence, at this stage of knowledge, it is not possible to predict the sensitivity of the patients to cytostatic chemotherapy based on the MN level, and even the data on the MN level in exfoliated epithelial cells of the patients under therapy are contradictory. In contrast, all studies showed a significant increment of MN in tumor and normal mucosal cells due to radiotherapy. This increment was dose-dependent. It is extremely important that a serial cytological assay of MN induction can potentially identify the radiosensitivity of tumors and the outcome of treatment. This technique is almost completely noninvasive and easily performed in accessible primary cancers like oral cavity and uterine cervix cancer. In other sites, a fine needle cytology can be tried.
In conclusion, an MN assay in epithelial tumors can be very useful in the prognosis of sensitivity of tumors to radiotherapy. As for MN assay in tumor patients treated with cytostatics, further investigations in this area are certainly warranted to evaluate the application of this test for prognosis of treatment outcome. 
